Sex, ApoE4 and Alzheimer's disease: rethinking drug discovery in the era of precision medicine

被引:0
|
作者
Paranjpe, Manish D. [1 ]
Wang, Jason K. [1 ]
Zhou, Yun [2 ]
机构
[1] Harvard Med Sch, Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA
[2] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA
关键词
GENOTYPE; RISK; AGE;
D O I
10.4103/1673-5374.306070
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
[No abstract available]
引用
收藏
页码:1764 / 1765
页数:2
相关论文
共 50 条
  • [31] Discovery of Isobavachin, a Natural Flavonoid, as an Apolipoprotein E4 (ApoE4) Structure Corrector for Alzheimer's Disease
    Patil, Sachin P.
    Kuehn, Bella R.
    Mccullough, Christina
    Bates, Dean
    Hazim, Hadil
    Diallo, Mamadou
    Francois, Naomie
    MOLECULES, 2025, 30 (04):
  • [32] Vascular pathology in ApoE3,3 and ApoE4,4 Alzheimer's Disease
    Hulette, CM
    Pannell, C
    Ervin, J
    Rosenberg, C
    Schmechel, D
    Saunders, AM
    Strittmatter, W
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (05): : 422 - 422
  • [33] Vascular pathology in ApoE4,4 and ApoE3,3 Alzheimer's disease
    Hulette, C
    Ervin, J
    Pannell, C
    Rosenberg, C
    Schmechel, D
    Strittmatter, A
    Saunders, A
    BRAIN PATHOLOGY, 2000, 10 (04) : 592 - 592
  • [34] APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia
    Michael S. Haney
    Róbert Pálovics
    Christy Nicole Munson
    Chris Long
    Patrik K. Johansson
    Oscar Yip
    Wentao Dong
    Eshaan Rawat
    Elizabeth West
    Johannes C. M. Schlachetzki
    Andy Tsai
    Ian Hunter Guldner
    Bhawika S. Lamichhane
    Amanda Smith
    Nicholas Schaum
    Kruti Calcuttawala
    Andrew Shin
    Yung-Hua Wang
    Chengzhong Wang
    Nicole Koutsodendris
    Geidy E. Serrano
    Thomas G. Beach
    Eric M. Reiman
    Christopher K. Glass
    Monther Abu-Remaileh
    Annika Enejder
    Yadong Huang
    Tony Wyss-Coray
    Nature, 2024, 628 : 154 - 161
  • [35] Sex Differences in Cortical Thickness and Neuropsychiatric Symptom Burden Based on APOE4 Homozygosity in Alzheimer's Disease
    Khoury, Marc A.
    Valcic, Mila
    Churchill, Nathan W.
    Di Battista, Alex
    De Luca, Vincenzo
    Fornazzari, Luis R.
    Munoz, David G.
    Fischer, Corinne E.
    Schweizer, Tom A.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2025, 198 (02)
  • [36] Functional vitamin E deficiency in ApoE4 patients with Alzheimer's disease
    Mas, E
    Dupuy, AM
    Artero, S
    Portet, F
    Cristol, JP
    Ritchie, K
    Touchon, J
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2006, 21 (03) : 198 - 204
  • [37] Roles of ApoE4 on the Pathogenesis in Alzheimer’s Disease and the Potential Therapeutic Approaches
    Yu-Ying Sun
    Zhun Wang
    Han-Chang Huang
    Cellular and Molecular Neurobiology, 2023, 43 : 3115 - 3136
  • [38] Tau haplotypes and ApoE4 do not act in synergy on Alzheimer's disease
    Almos, Peter Z.
    Horvath, Szatmar
    Czibula, Agnes
    Rasko, Istvan
    Domjan, Nora
    Juhasz, Anna
    Janka, Zoltan
    Kalman, Janos
    PSYCHIATRY RESEARCH, 2011, 186 (2-3) : 448 - 450
  • [39] APOE4 affects neutrophil-microglia crosstalk in Alzheimer's disease
    Terrabuio, Eleonora
    Constantin, Gabriela
    TRENDS IN IMMUNOLOGY, 2024, 45 (10)
  • [40] APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease
    Fortea, Juan
    Pegueroles, Jordi
    Alcolea, Daniel
    Belbin, Olivia
    Dols-Icardo, Oriol
    Vaque-Alcazar, Lidia
    Videla, Laura
    Gispert, Juan Domingo
    Suarez-Calvet, Marc
    Johnson, Sterling C.
    Sperling, Reisa
    Bejanin, Alexandre
    Lleo, Alberto
    Montal, Victor
    NATURE MEDICINE, 2024, 30 (5) : 1284 - 1291